Theravance Biopharma, Inc. (TBPH)
16.51
-0.16
(-0.96%)
USD |
NASDAQ |
May 14, 16:00
16.10
-0.41
(-2.48%)
After-Hours: 20:00
Theravance Biopharma Free Cash Flow : 268.74M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viatris, Inc. | 1.643B |
| Relmada Therapeutics, Inc. | -42.79M |
| Indivior Pharmaceuticals, Inc. | -193.86M |
| Corcept Therapeutics, Inc. | 119.79M |
| Assertio Holdings, Inc. | -7.081M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 73.28M |
| Cash from Investing (Quarterly) | 52.59M |
| Cash from Financing (Quarterly) | -5.577M |
| Free Cash Flow Per Share (Quarterly) | 1.429 |
| Free Cash Flow to Equity (Quarterly) | 75.48M |
| Free Cash Flow to Firm (Quarterly) | 73.28M |
| Free Cash Flow Yield | 31.46% |